HELP BRING MIFEPRISTONE TO AMERICAN WOMEN!

American women have been denied access by the FDA to mifepristone, the
French abortion pill RU486, for over 10 years, even though the FDA has
maintained since 1996 that mifepristone is safe and effective.
Mifepristone
enables a woman to safely end an early pregnancy non-surgically. In
addition, mifepristone has many potential medical uses outside of
abortion,
including treatment of ovarian and breast cancer, endometriosis, and brain
tumors.

American women have been denied access by the FDA to mifepristone, the
French abortion pill RU486, for over 10 years, even though the FDA has
maintained since 1996 that mifepristone is safe and effective.
Mifepristone
enables a woman to safely end an early pregnancy non-surgically. In
addition, mifepristone has many potential medical uses outside of
abortion,
including treatment of ovarian and breast cancer, endometriosis, and brain
tumors.

TAKE A LOOK AT THESE FACTS:

**Number of women in the U.S. killed by breast cancer in 1999: 43,000
**Percentage of breast cancer tumors experts believe mifepristone may
effectively treat: 40

**Number of deaths known to be caused by Viagra, a drug with fewer
restrictions than those proposed for mifepristone: 60
**Number of deaths known to be caused by mifepristone: 0

**Number of months it took the FDA to approve Viagra: 5
**Number of years since the FDA concluded that mifepristone is safe and
effective: 4
**Number of years since the first clinical trials of mifepristone in the
U.S.: 17
**Number of years mifepristone has been effectively used in France: 12

**Percentage of U.S. counties where abortion services are unavailable: 86

**Percentage of Ob/Gyns who do not perform abortions but said they would
offer mifepristone if it were approved: 54

**Percentage of women who participated in U.S. clinical trials of
mifepristone who said they would recommend it to others: 96

**Increase in the total number of abortions in France since method was
introduced in 1989: 0

THE FDA IS NOW PROPOSING TO APPROVE MIFEPRISTONE WITH THE FOLLOWING
RESTRICTIONS ON ITS USE:

1: limiting distribution of the drug to physicians who are trained to
perform surgical abortions (even though standard medical abortion protocol
requires arrangements for surgical back-up);

2: requiring doctors trained in the use of mifepristone to be registered
with the drug’s distributor (a disincentive for doctors wary of being
formally identified as abortion providers);

3: restricting distribution of the drug to doctors who have admitting
priveleges at a hospital within an hour of their office (even though all
hospitals are already required to treat emergency situations).

These restrictions undermine mifepristone’s impressive safety record and
severely limit its potential to provide access to medical services for
American women.

WHAT CAN YOU DO TO HELP?

Act ASAP, but before late September…

· Call the White House and tell Bill Clinton to use his presidential power
to advocate for mifepristone(RU-486)approval with no restrictions:
202-456-1414

· Go to THE FDA WEBSITE and
click
on “e-mail” for comments. Include the docket number 95P0054 for
mifepristone, and send your e-mail comments.
Tell them to approve mifepristone without restriction.

PLEASE FORWARD THIS ARTICLE TO YOUR FRIENDS AND COLLEAGUES.

Author: the Institute for Reproductive Health Access

News Service: the NARAL/NY

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: